Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 48.30
-2.54 (-5.00%)
At close: Jan 20, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 19.09 billion as of January 23, 2026. Its market cap has increased by 176.30% in one year.
Market Cap
19.09B
Enterprise Value
19.00B
Revenue
362.10M
Ranking
n/a
PE Ratio
229.83
Stock Price
48.30
Market Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 19.09B, an increase of 41,258.44%. That is a compound annual growth rate of 54.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 19.09B | -26.41% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 31.21B |
| Unichem Laboratories | 26.52B |
| Hikal | 24.72B |
| Novartis India | 19.40B |
| Morepen Laboratories | 18.98B |
| Amrutanjan Health Care | 17.71B |
| Bliss GVS Pharma | 16.26B |
| TTK Healthcare | 14.14B |